Metropolis Healthcare

Capable of conducting 60,000 sample testing per month

Records strong growth in Q1FY22 Revenue, EBITDA & PAT

The test will identify patient’s need for ventilation or ICU facilities and help reduce stress on healthcare resources

The 1,000 sq ft laboratory has the capacity to conduct more than 60,000 sample testing per month

According to India TB Report 2021, the NGS test has already been recommended by the Central TB division as a preferred diagnostic…

Over 280 registrations were received from across the country

The COVID-19 pandemic has shaken out the kinks in India’s diagnostics sector. Today, pandemic panic has given way to increased…

Recognition was also given to Metropolis Healthcare's support in India’s fight against COVID-19 in 2020

The board of directors have declared an interim dividend of Rs 8 per share, the filing said

Diagnostics companies hope to benefit from the focus on preventive healthcare in the Union Budget 2021, as this could encourage…